DongKook Pharmaceutical Co. Ltd (086450) — Long-term Investment Intensity
DongKook Pharmaceutical Co. Ltd (086450) has a Long-term Investment Intensity of 6.5% as of December 2019. Long-term investments of ₩35.48 Billion represent 6.5% of total assets of ₩544.38 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 086450 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DongKook Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how DongKook Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 6.5%, reflecting long-term investments of ₩35.48 Billion against total assets of ₩544.38 Billion KRW. For the complete balance sheet picture, see total assets of DongKook Pharmaceutical Co. Ltd.
Annual Long-term Investment Intensity for DongKook Pharmaceutical Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for DongKook Pharmaceutical Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 086450 liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 6.5% | ₩35.48 Billion | ₩544.38 Billion | ▲ +0.8 pp |
| 2018 | 5.8% | ₩27.63 Billion | ₩480.24 Billion | ▲ +0.2 pp |
| 2017 | 5.5% | ₩20.56 Billion | ₩373.31 Billion | ▲ +1.0 pp |
| 2016 | 4.6% | ₩14.80 Billion | ₩325.10 Billion | ▲ +0.1 pp |
| 2015 | 4.4% | ₩12.21 Billion | ₩274.80 Billion | ▲ +1.2 pp |
| 2014 | 3.2% | ₩7.89 Billion | ₩244.17 Billion | — |